LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Bicara Therapeutics (NASDAQ: BCAX)

Follow NASDAQ:BCAX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ BCAX Bicara Therapeutics
Mazumdar Claire / director, officer: Chief Executive Officer
12/16/2025
Sell
$5.45
29,500
$161K
565,512
NASDAQ BCAX Bicara Therapeutics
Mazumdar Claire / director, officer: Chief Executive Officer
12/16/2025
Buy
$5.45
29,500
$161K
339,392
NASDAQ BCAX Bicara Therapeutics
Cohlhepp Ryan / director, officer: President and COO
12/15/2025
Buy
$3.79
8,000
$30K
201,641
NASDAQ BCAX Bicara Therapeutics
Cohlhepp Ryan / director, officer: President and COO
12/15/2025
Sell
$18.68
8,000
$149K
193,641
NASDAQ BCAX Bicara Therapeutics
Cohlhepp Ryan / director, officer: President and COO
12/15/2025
Sell
$18.68
4,500
$84K
189,141
NASDAQ BCAX Bicara Therapeutics
Cohlhepp Ryan / director, officer: President and COO
12/15/2025
Sell
$3.79
8,000
$30K
141,334
NASDAQ BCAX Bicara Therapeutics
Hyep Ivan / officer: Chief Financial Officer
11/24/2025
Buy
$3.79
17,795
$67K
163,150
NASDAQ BCAX Bicara Therapeutics
Hyep Ivan / officer: Chief Financial Officer
11/21/2025
Buy
$3.79
605
$2K
145,960
NASDAQ BCAX Bicara Therapeutics
Hyep Ivan / officer: Chief Financial Officer
11/24/2025
Sell
$18.55
17,795
$330K
145,355
NASDAQ BCAX Bicara Therapeutics
Hyep Ivan / officer: Chief Financial Officer
11/21/2025
Sell
$18.15
605
$11K
145,355
NASDAQ BCAX Bicara Therapeutics
Hyep Ivan / officer: Chief Financial Officer
11/21/2025
Sell
$3.79
605
$2K
115,979
NASDAQ BCAX Bicara Therapeutics
Hyep Ivan / officer: Chief Financial Officer
11/24/2025
Sell
$3.79
17,795
$67K
98,184
NASDAQ BCAX Bicara Therapeutics
Cohlhepp Ryan / director, officer: President and COO
11/21/2025
Buy
$3.79
8,000
$30K
206,141
NASDAQ BCAX Bicara Therapeutics
Cohlhepp Ryan / director, officer: President and COO
11/21/2025
Sell
$18.05
8,000
$144K
198,141
NASDAQ BCAX Bicara Therapeutics
Cohlhepp Ryan / director, officer: President and COO
11/21/2025
Sell
$18.05
4,500
$81K
193,641
NASDAQ BCAX Bicara Therapeutics
Cohlhepp Ryan / director, officer: President and COO
11/21/2025
Sell
$3.79
8,000
$30K
149,334
NASDAQ BCAX Bicara Therapeutics
Mazumdar Claire / director, officer: Chief Executive Officer
11/24/2025
Buy
$3.79
41,163
$156K
351,055
NASDAQ BCAX Bicara Therapeutics
Mazumdar Claire / director, officer: Chief Executive Officer
11/24/2025
Sell
$18.86
41,163
$776K
309,892
NASDAQ BCAX Bicara Therapeutics
Mazumdar Claire / director, officer: Chief Executive Officer
11/24/2025
Sell
$3.79
41,163
$156K
236,107
NASDAQ BCAX Bicara Therapeutics
Raben David / officer: Chief Medical Officer
11/24/2025
Sell
$3.79
5,500
$21K
123,370
NASDAQ BCAX Bicara Therapeutics
Raben David / officer: Chief Medical Officer
11/25/2025
Sell
$3.79
4,594
$17K
118,776
NASDAQ BCAX Bicara Therapeutics
Raben David / officer: Chief Medical Officer
11/25/2025
Sell
$3.79
906
$3K
69,413
NASDAQ BCAX Bicara Therapeutics
Raben David / officer: Chief Medical Officer
11/24/2025
Buy
$3.79
5,500
$21K
40,997
NASDAQ BCAX Bicara Therapeutics
Raben David / officer: Chief Medical Officer
11/25/2025
Buy
$3.79
4,594
$17K
40,091
NASDAQ BCAX Bicara Therapeutics
Raben David / officer: Chief Medical Officer
11/25/2025
Buy
$3.79
906
$3K
36,403
NASDAQ BCAX Bicara Therapeutics
Raben David / officer: Chief Medical Officer
11/25/2025
Sell
$18.84
906
$17K
35,497
NASDAQ BCAX Bicara Therapeutics
Raben David / officer: Chief Medical Officer
11/24/2025
Sell
$18.45
5,500
$101K
35,497

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous